The federal litigation in Illinois has added more than 1,000 testosterone lawsuits since its creation in June 2014. Our Firm sees this as evidence that the proceeding will continue to progress significantly.
New York, NY (PRWEB) February 28, 2015
A case management conference (http://www.testosteronelawsuithub.com/ ) to discuss federal testosterone lawsuits that have been filed by law firms including Bernstein Liebhard LLP has been scheduled for the second week in March, the Firm notes.
According to a Calendar posted on the Court’s website, parties involved in the federal litigation will meet on March 13, 2015 at 1:30 p.m. to address matters related to prescription therapy treatments designed to raise levels of the male hormone. The conference will take place in the U.S. District Court, Northern District of Illinois, where hundreds of claims have been filed over certain testosterone medications that have been blamed for heart attacks, strokes, sudden cardiac death and other cardiovascular injuries sustained by men taking them. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
“The federal litigation in Illinois has added more than 1,000 testosterone lawsuits since its creation in June 2014. Our Firm sees this as evidence that the proceeding will continue to progress significantly in the coming months, as attorneys continue to represent individuals who were allegedly harmed by testosterone products,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including those designed to raise testosterone levels. The Firm is actively filing testosterone lawsuits on behalf of men who allege sudden cardiac death, cardiopulmonary arrest, strokes and other serious heart injuries.
According to a listed number of cases found on the Northern District of Illinois’ website, more than 1,147 testosterone lawsuits had been centralized in the proceeding at the end of February 2015. All these cases, including the ones filed by attorneys at Bernstein Liebhard LLP, follow the federal litigation’s creation in June 2014, and a public health alert issued a few months earlier by the U.S. Food and Drug Administration (FDA). According to the federal agency’s notice on January 31, 2014, certain testosterone medications may cause an increased risk of cardiovascular injuries in younger men with a pre-existing history of heart disease and all older men older than 65.
A federal panel convened by the FDA then met in September 2014 to further discuss the issue, and recommended that the labeling on testosterone products be revised to make clear that they have not been proven effective in treating low libido, loss of muscle mass, fatigue and other issues that often occur in men as they age. Advisers also recommended that testosterone manufacturers be required to conduct large-scale studies to assess their possible association with heart problems.
According to court documents, all the testosterone lawsuits now pending in Illinois federal court allege life-threatening cardiovascular injuries, as well as deep vein thrombosis and pulmonary embolism, caused by several medications. Plaintiffs in these cases further allege that manufacturers of these products concealed these risks in order to protect their market share.
Men who allegedly sustained serious cardiovascular problems due to their use of prescription testosterone treatments may be eligible to receive compensation for injury-related damages. Learn more about the benefits of speaking with a testosterone lawyer by visiting Bernstein Liebhard LLP’s website. No-obligation legal consultations can also be obtained by calling 800-5092.
*http://reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP